Primary tabs

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

An Open-Label Randomized Efficacy and Safety Study of Infliximab Versus Methotrexate in the Treatment of Moderate to Severe Psoriasis

The primary objective of this trial is to assess the efficacy of infliximab therapy 5mgkg by body weight compared with methotrexate in adult subjects aged 18-75 years diagnosed with moderate to severe plaque-type psoriasis for at least 6 months prior to study screening subjects with concurrent psoriatic arthritis may also be enrolled

FieldValue
Modified
2020-03-29
Release Date
2018-08-11
Identifier
1e90fcba-db0f-42ab-b1c5-76633530fc1b
License
Public Access Level
Public